Robert A Wood, R Sharon Chinthrajah, Amanda K Rudman Spergel, Denise C Babineau, Scott H Sicherer, Edwin H Kim, Wayne G Shreffler, Stacie M Jones, Donald Y M Leung, Brian P Vickery, J Andrew Bird, Jonathan M Spergel, Michael Kulis, Ahmar Iqbal, Derrick Kaufman, Dale T Umetsu, Monica Ligueros-Saylan, Alkaz Uddin, Robert B Fogel, Stephanie Lussier, Kim Mudd, Julian Poyser, Martin MacPhee, Maria Veri, Wendy Davidson, Sanaz Hamrah, Andrew Long, Alkis Togias
BACKGROUND: Food allergy is common and causes substantial morbidity and even mortality. Safe and effective treatments for food allergy would therefore be highly desirable, especially for individuals with multiple food allergies. OBJECTIVES: Our aim was to describe a phase 3 study on treatment of patients with multiple food allergies with omalizumab. METHODS: The study was developed as a collaboration between the Consortium for Food Allergy Research, the National Institute of Allergy and Infectious Diseases, and 2 industry sponsors (Genentech and Novartis)...
November 2022: J Allergy Clin Immunol Glob